FIELD: biotechnologies.
SUBSTANCE: method is based on assessment of ACTN3 genotype, where genotype 577RR is positively related to sprinter or power abilities; genotype 577XX is negatively related to sprinter or power abilities; genotype 577XX is positively related to stamina; genotype 577RX is positively related to sprinter or power abilities; and genotype 577RX is negatively related to stamina in women.
EFFECT: method makes it possible to select type of sports or competitions for an individual, for instance speed-power type of sports or type of sports that requires stamina, and to develop more optimal training regime for a single sportsman.
1 dwg, 6 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETERMINING PREDISPOSITION TO LONG PHYSICAL EFFORT | 2011 |
|
RU2468086C1 |
| GENETIC PANEL AND METHOD FOR DETERMINATION OF PREDISPOSITION OF PERSON TO VARIOUS KINDS OF PHYSICAL WORKING CAPACITY | 2006 |
|
RU2339701C2 |
| GENETIC POLYMORPHISMS ACCOMPANYING AGE-RELATED MACULAR DEGENERATION | 2010 |
|
RU2546008C2 |
| GENETIC POLYMORPHISMS IN AGE-RELATED MACULAR DEGENERATION | 2010 |
|
RU2577726C2 |
| METHOD OF PROFESSIONAL SELECTION OF EMPLOYEES OF POWER DEPARTMENTS AND PERSONS WHOSE ACTIVITIES ARE ASSOCIATED WITH HIGH RISK TO LIFE AND HEALTH, FOR EFFECTIVE PERFORMANCE OF SERVICE ACTIVITIES IN EXTREME CONDITIONS | 2019 |
|
RU2741342C1 |
| METHOD OF DETERMINING PHYSICAL CAPABILITY OF HUMAN BEING | 2008 |
|
RU2414511C2 |
| METHOD FOR TREATMENT WITH BUCINDOLOL BASED ON GENOTYPE DEFINITION | 2005 |
|
RU2389798C2 |
| VEGF POLYMORPHISM AND ANTIANGIOGENESIS THERAPY | 2008 |
|
RU2482491C2 |
| GENETIC MARKERS FOR PREDICTING SENSITIVITY TO THERAPY | 2014 |
|
RU2809215C2 |
| VEGF POLYMORPHISM AND ANTIANGIOGENESIS THERAPY | 2013 |
|
RU2635525C2 |
